MiniMed Group, Inc.

MiniMed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for managing diabetes. The company provides technologies such as insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves individuals with diabetes who need insulin therapy, which includes all people with Type 1 Diabetes (T1D) and a subset of those with Type 2 Diabetes (T2D). The company's platform features Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration to control blood sugar. It also offers Smart Multiple Daily Injection (MDI) systems for self-administering insulin through manual injections, which include InPen, Simplera, or Guardian 4, along with accompanying applications and services. MiniMed Group, Inc. was founded in 1983 and is based in Northridge, California.